â– LECTURE OVERVIEW: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer, HNPCC) is an autosomal dominant cancer predisposition syndrome characterized by defective DNA mismatch repair.
â– GENETIC AND BIOCHEMICAL BIOCHEMISTRY:
1. Mismatch Repair (MMR) Defect: Caused by germline mutations in DNA Mismatch Repair genes, primarily MSH2, MLH1, MSH6, and PMS2.
2. Single-Base Mispairings: During S-phase replication, DNA polymerases can accidentally introduce single-base mispairs or small insertion-deletion loops.
3. Splicing Corrections: The MMR system scans newly synthesized strands, excises mispaired bases, and resynthesizes correct sequences.
4. Microsatellite Instability (MSI): Microsatellites are short, repetitive, non-coding DNA sequences prone to polymerase slippage. When MMR is defective, these repeat lengths mutate rapidly, creating a hypermutable state termed Microsatellite Instability (MSI).
5. Two-Hit Hypothesis: Tumorigenesis occurs when the somatic wild-type allele is mutated (second-hit), driving rapid progression of colon adenomas into invasive carcinomas.
â– THERAPEUTIC TARGETS & MANAGEMENT:
Primary pharmacological intervention aims to restore physiological homeostatic balance. This is achieved by either competitively blocking receptor sites, allosterically inhibiting enzymes, or supplementing missing metabolic products.
â– EVIDENCE-BASED GUIDELINE SYNOPSIS:
Recent international multi-center guidelines emphasize starting therapeutic interventions immediately upon diagnosis to minimize long-term target organ strain.
[HY-BOARD-1044]
🌟 Dynamic Clinical Key:
Lynch syndrome predisposes patients to proximal (right-sided) colon cancers with a notable lack of heavy pre-existing polyposis. It is also associated with a massive lifetime risk of endometrial cancer in women, as well as ovarian, gastric, small bowel, and transitional cell urothelial tract carcinomas. Absolute contraindications include pregnancy, renal insufficiency, or concurrent use of metabolic inhibitors. Consult updated medical consensus reports to align treatment protocols with modern precision standards.